🇺🇸 FDA
Patent

US 9346822

Thienopyrimidine compounds and use thereof

granted A61KA61K31/519A61P

Quick answer

US patent 9346822 (Thienopyrimidine compounds and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/519, A61P, A61P1/00, A61P1/04